
Analysis of Antidepressant Paxil Finds Data on Teen Risk Was Held Back
Drugmaker GlaxoSmithKline is criticized for delaying access to data about its antidepressant paroxetine (Seroxat, Paxil) that would have shown earlier that it is neither safe or effective in adolescents










